BMO US Equity Class Advisor (BMO85602)
32.30
+0.44 (+1.38%)
CAD |
May 13 2022
Returns Chart
Key Stats
Customize
Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
---|---|---|---|
2.51% | 76.95M | 0.00% | 41.69% |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
-5.406M | 1.83% | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The fund’s investment objective is to provide long term growth through capital appreciation, by investing primarily in equities and equity-related securities of U.S. companies. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | BMO85602 |
Equity Style | Large Cap/Blend |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | US Equity |
Category Index | Morningstar US Market GR CAD |
Prospectus Objective | -- |
Fund Owner Firm Name | BMO Investments Inc. |
Prospectus Benchmark Index | |
S&P 500 TR CAD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
Ernesto Ramos | 8.92 yrs |
Jason Hans | 7.50 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
72
-5.406M
-571.71M
Category Low
2.838B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2022
Performance Versus Category
As of May 13, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 13, 2022.
Asset Allocation
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
Microsoft Corp | 7.59% | 261.27 | 0.06% |
Apple Inc | 6.30% | 145.26 | -1.26% |
Alphabet Inc Class C | 4.99% | 2292.95 | -1.60% |
Amazon.com Inc | 3.34% | 2214.72 | -2.05% |
Meta Platforms Inc Class A | 2.35% | 199.65 | 0.52% |
EOG Resources Inc | 2.20% | 126.49 | 1.78% |
Vertex Pharmaceuticals Inc | 2.03% | 254.29 | 3.07% |
Walmart Inc | 1.93% | 148.08 | 0.02% |
AutoZone Inc | 1.92% | 2024.32 | 1.16% |
Merck & Co Inc | 1.80% | 92.24 | 2.02% |
Basic Info
Investment Strategy | |
The fund’s investment objective is to provide long term growth through capital appreciation, by investing primarily in equities and equity-related securities of U.S. companies. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | BMO85602 |
Equity Style | Large Cap/Blend |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | US Equity |
Category Index | Morningstar US Market GR CAD |
Prospectus Objective | -- |
Fund Owner Firm Name | BMO Investments Inc. |
Prospectus Benchmark Index | |
S&P 500 TR CAD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
Ernesto Ramos | 8.92 yrs |
Jason Hans | 7.50 yrs |
Fundamentals
General | |
Distribution Yield | Upgrade |
Dividend Yield TTM (5-13-22) | 0.00% |
30-Day SEC Yield | -- |
7-Day SEC Yield | -- |
Number of Holdings | Upgrade |
Stock | |
Weighted Average PE Ratio | 22.42 |
Weighted Average Price to Sales Ratio | Upgrade |
Weighted Average Price to Book Ratio | Upgrade |
Weighted Median ROE | Upgrade |
Weighted Median ROA | Upgrade |
Forecasted Dividend Yield | Upgrade |
Forecasted PE Ratio | Upgrade |
Forecasted Price to Sales Ratio | Upgrade |
Forecasted Price to Book Ratio | Upgrade |
As of March 31, 2022
Growth Estimates
Fund Details
Key Dates | |
Inception Date | 11/3/2008 |
Last Annual Report Date | 9/30/2021 |
Last Prospectus Date | -- |
Share Classes | |
BMO31602 | Commission-based Advice |
BMO77602 | -- |
BMO81602 | Commission-based Advice |
BMO88602 | Fee-based Advice |
Attributes | |
Enhanced Index Fund | No |
Index Fund | No |
Inverse Fund | No |
Leveraged Fund | No |
Fund of Funds | No |
Currency Hedged Fund | No |
Synthetic Replication Fund | No |
Has Dividend Investment Plan | No |
Socially Responsible Fund | No |